We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Active Implantable Medical Devices Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Active implantable medical devices such as cardiac pacemaker systems, cochlear implants, implantable infusion pumps, cardiac resynchronization therapy devices aid in improving patient’s health and outcome of the medical treatment. Active implantable medical devices are prosthetic devices, which provide support in functioning of organs. For instance, pacemakers and defibrillators are capable of monitoring the heart rhythm. Pacemakers replace the natural pacemaker of the heart i.e. sinoatrial node (SA node) and defibrillator, monitors the heart rhythm and can prevent cardiac arrest. These devices come under Class II and some under Class III devices in the U.S. FDA medical devices listing and are subject to stringent regulations as they pose surgical risks during placement, bruising at surgical site, pain, and high risks due to implant failure. The active implantable medical devices market is dominated by few leading players such as Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, and Cochlear Ltd. accounting for over 70% of the market share.
Market Dynamics
Advancements in technology such as magnetic resonance imaging (MRI) compatible pacemakers and growing support in favor of use of such devices in cardiovascular and chronic pain diseases is expected to boost growth of the active implantable medical devices market. For instance, in November 2017, American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Rhythm Society (HRS) approved the use of subcutaneous implantable cardioverter defibrillator, (S-ICD), for the treatment of ventricular arrhythmias and to prevent cardiac arrest. Major manufacturers in the market are focusing on collaborations and mergers and acquisitions and are increasingly investing in research and development of implantable devices. For instance, merger of Sorin Group and Cyberonics to form LivaNova Plc in 2015. Furthermore, effectiveness of these devices in improving medical outcomes of cardiovascular and chronic pain diseases, absence of effective alternatives to these devices and continuous product launches is expected to fuel growth of the market.
Key features of the study:

This report provides in-depth analysis of active implantable medical devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global active implantable medical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the active implantable medical devices market

Detailed Segmentation:

Global Active Implantable Medical Devices Market, By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

Global Active Implantable Medical Devices Market, By Geography:

North America

By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

By Country:

U.S.
Canada


Europe

By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe


Asia Pacific

By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific


Latin America

By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

By Country:

Brazil
Mexico
Rest of Latin America


Middle East

By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

By Country:

GCC
Israel
Rest of Middle East


Africa

By Product Type:

Pacemakers
Implantable Cardioverter Defibrillators (ICD)
Cardiac Resynchronization Therapy Devices (CRT-D)
Neurostimulators
Drug Infusion Pumps
Implantable Loop Recorders
Cochlear Implants
Others

By Country:

Central Africa
South Africa
North Africa



Company Profiles

Cochlear Limited*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments


Boston Scientific Corporation
Medtronic Plc.
LivaNova Plc.
Abbott Laboratories
Sonova Holding AG
William Demant holding A/S
Nurotron Biotechnology Co. Ltd.
Med-EL



 “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Pricing Analysis
o PEST Analysis
o PORTER's Five Forces Analysis
o Regulatory Scenario
o Technological Evolution
4. Global Active Implantable Medical Devices Market, By Product Type, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Pacemakers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Implantable Cardioverter Defibrillators (ICD)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Cardiac Resynchronization Therapy Devices (CRT-D)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Neurostimulators
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Drug Infusion Pumps
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Implantable Loop Recorders
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Cochlear Implants
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
5. Global Active Implantable Medical Devices Market, By Region, 2015-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Product Type, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
6. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Cochlear Limited
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Boston Scientific Corporation
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Medtronic Plc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? LivaNova Plc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Abbott Laboratories
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sonova Holding AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? William Demant holding A/S
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Nurotron Biotechnology Co. Ltd.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Med-EL
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
7. Section
o Research Methodology
o About us and Sales Contact
*Browse 30 market data tables and 56 figures on "Active Implantable Medical Devices Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.